Your browser doesn't support javascript.
loading
Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery.
Wurnig, Christian; Clemens, Andreas; Rauscher, Helmuth; Kleine, Eva; Feuring, Martin; Windhager, Reinhard; Grohs, Josef.
Affiliation
  • Wurnig C; Orthopaedisches Spital, Speisinger Strasse 109, 1130 Vienna, Austria.
  • Clemens A; Center for Thrombosis and Hemostasis, University Medical Center Mainz, Mainz, Germany ; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
  • Rauscher H; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
  • Kleine E; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
  • Feuring M; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.
  • Windhager R; Department of Orthopaedics, Medical University Vienna, Vienna, Austria.
  • Grohs J; Department of Orthopaedics, Medical University Vienna, Vienna, Austria.
Thromb J ; 13: 37, 2015.
Article in En | MEDLINE | ID: mdl-26612979
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies Language: En Journal: Thromb J Year: 2015 Document type: Article Affiliation country: Austria Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies Language: En Journal: Thromb J Year: 2015 Document type: Article Affiliation country: Austria Country of publication: United kingdom